Actuate Therapeutics, Inc.

ACTU chart

Actuate Therapeutics, Inc. news

• Actuate Therapeutics, Inc. Common stock (ACTU) Seasonal Returns Chart - Yahoo Finance

  Yahoo! Finance Canada · Nov 6, 4:00 PM EST

• Actuate Therapeutics to Present Promising Preclinical Data Demonstrating Antitumor and Immune Activation Activity of Elraglusib Oral Tablet in Advanced Melanoma Models at ENA 2026

  Yahoo Finance · Nov 4, 8:00 AM EST

• An experimental tablet slowed melanoma tumors in mice. Patient testing is planned for early 2027.

  Stock Titan · Nov 4, 8:00 AM EST

• Elraglusib oral tablet shows strong tumor inhib...

  Pluang · Nov 4, 3:00 AM EST

• Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets

  Yahoo Finance · Nov 2, 8:00 AM EST

• Actuate Therapeutics Announces Pricing of $11.0 Million Underwritten Public Offering

  Yahoo Finance · Oct 27, 8:00 AM EDT

• TEVA Gets FDA Nod for Weltruza as Once-Monthly LAI in Schizophrenia

  Yahoo Finance · Oct 12, 11:07 AM EDT

• AbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in Cancer

  Yahoo Finance · Oct 8, 10:47 AM EDT

• Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference

  Yahoo Finance · Sep 9, 5:00 PM EDT

• Actuate Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with RAS Inhibitors Zoldonrasib and Daraxonrasib

  Yahoo Finance · Sep 9, 7:00 AM EDT

• Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

  Yahoo Finance · Jun 9, 7:45 AM EDT

• Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer

  Yahoo Finance · Jun 1, 7:00 AM EDT

Actuate Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-KCURRENT REPORT2026-10-30
• 8-KFORM 8-K2026-10-28
• S-1REGISTRATION STATEMENT2026-10-06
• 10-QFORM 10-Q FOR JUN 20262026-08-14
• 8-KCURRENT REPORT2026-07-17
• 8-KCURRENT REPORT2026-05-22
• 10-QFORM 10-Q FOR MAR 20262026-05-14
• 8-KFORM 8-K2026-05-11
• 8-KCURRENT REPORT2026-05-06
• DEF 14ADEF 14A2026-04-06
• 10-KFORM 10-K FOR DEC 20252026-03-26
• 8-KFORM 8-K2026-01-12

About Actuate Therapeutics, Inc.

Ticker

ACTU (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Fort Worth, TX

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1652935

Frequently asked questions